Barclays
ZURA icon

Barclays’s Zura Bio ZURA Stock Holding History

Barclays’s Portfolio ZURA Stock Details ZURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$624K Sell
105,746
-64,087
-38% -$305K ﹤0.01% 3094
2026
Q1 		$1.01M Buy
169,833
+121,172
+249% +$732K ﹤0.01% 2758
2025
Q4 		$255K Buy
48,661
+48,659
+2,432,950% +$192K ﹤0.01% 4198
2025
Q3 		$9 Hold
2
– – ﹤0.01% 5402
2025
Q2 		$2 Sell
2
-55,757
-100% -$66.7K ﹤0.01% 5191
2025
Q1 		$71.9K Sell
55,759
-22,764
-29% -$35.9K ﹤0.01% 4507
2024
Q4 		$196K Buy
78,523
+14,462
+23% +$51.5K ﹤0.01% 4323
2024
Q3 		$260K Buy
64,061
+56,757
+777% +$212K ﹤0.01% 4158
2024
Q2 		$25.6K Sell
7,304
-5,032
-41% -$20.5K ﹤0.01% 4396
2024
Q1 		$31.7K Sell
12,336
-11,275
-48% -$40K ﹤0.01% 4695
2023
Q4 		$110K Buy
23,611
+21,406
+971% +$107K ﹤0.01% 4618
2023
Q3 		$14.6K Buy
2,205
+696
+46% +$4.65K ﹤0.01% 4238
2023
Q2 		$12.4K Buy
+1,509
New +$12.1K ﹤0.01% 4205

Other funds holding ZURA

SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
VA
VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.64B AUM 245.64% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $529M AUM 337.4% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CC
Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

Barclays's ZURA Position: Q2 2026 in Review

Barclays reduced its Zura Bio (ZURA) stake by 38% in Q2 2026, selling an estimated $305K and leaving 105,746 shares worth $624K. The position accounts for ﹤0.01% of the portfolio, ranked #3094.

Barclays first reported a position in ZURA in Q2 2023 and has held it in 13 quarters since. The position peaked at $1.01M in Q1 2026. 95 funds tracked by Wall St. Rank hold ZURA as of Q2 2026.

  • Barclays held 105,746 shares of Zura Bio worth $624K as of Q2 2026.
  • Barclays sold 64,087 Zura Bio shares in Q2 2026, an estimated $305K.
  • Zura Bio made up ﹤0.01% of Barclays's portfolio in Q2 2026, its #3094 holding.
  • Barclays first reported a position in Zura Bio in Q2 2023 and has held it in 13 quarters since.
  • Barclays's Zura Bio position peaked at $1.01M in Q1 2026.
  • 95 funds tracked by Wall St. Rank held Zura Bio as of Q2 2026.

Based on Barclays's 13F filing for Q2 2026, filed 14 Aug 2026.